William H. McMullan
William H. McMullan is a Managing Director at The Carlyle Group focused on buyouts, privatizations and strategic minority investments in the healthcare sector. Mr. McMullan is based in New York.
Mr. McMullan serves as a member of the board of directors of Albany Molecular Research, Inc (AMRI), Medrisk, Millicent Pharma, Sedgwick, Welldyne, LifeCare Holdings (prior) and Grupo Qualicorp (prior). Mr. McMullan has also been actively involved in a number of other investments including Rede D’Or São Luiz S.A., and Multiplan (prior). Prior to joining Carlyle, Mr. McMullan was with J.W. Childs Associates in Boston.
Mr. McMullan received an M.B.A. from Harvard University and a B.S., in economics with a minor in computer science, from Duke University.